An ADME Study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604
Clinical trial NCT06157255 · COMPLETED
Trial details
- NCT number
- NCT06157255
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-16
- Primary completion
- 2024-05-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.